Charles River Laboratories International (CRL) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $207.1 million.
- Charles River Laboratories International's Cash & Current Investments fell 146.26% to $207.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.1 million, marking a year-over-year decrease of 146.26%. This contributed to the annual value of $194.6 million for FY2024, which is 2968.7% down from last year.
- According to the latest figures from Q3 2025, Charles River Laboratories International's Cash & Current Investments is $207.1 million, which was down 146.26% from $182.8 million recorded in Q2 2025.
- Over the past 5 years, Charles River Laboratories International's Cash & Current Investments peaked at $465.4 million during Q1 2021, and registered a low of $157.2 million during Q3 2023.
- In the last 5 years, Charles River Laboratories International's Cash & Current Investments had a median value of $210.2 million in 2024 and averaged $230.4 million.
- Per our database at Business Quant, Charles River Laboratories International's Cash & Current Investments tumbled by 4803.11% in 2022 and then surged by 6223.22% in 2024.
- Charles River Laboratories International's Cash & Current Investments (Quarter) stood at $241.2 million in 2021, then decreased by 3.03% to $233.9 million in 2022, then increased by 18.32% to $276.8 million in 2023, then decreased by 29.69% to $194.6 million in 2024, then rose by 6.42% to $207.1 million in 2025.
- Its Cash & Current Investments stands at $207.1 million for Q3 2025, versus $182.8 million for Q2 2025 and $229.4 million for Q1 2025.